2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular …

N Marx, M Federici, K Schütt… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes …

F Cosentino, PJ Grant, V Aboyans… - European heart …, 2020 - academic.oup.com
Health professionals are encouraged to take the Guidelines fully into account when
exercising their clinical judgment, as well as in the determination and the implementation of …

[PDF][PDF] Oxidative stress and inflammatory markers in prediabetes and diabetes.

K Luc, A Schramm-Luc, TJ Guzik… - Journal of Physiology & …, 2019 - researchgate.net
Prediabetes is a state of elevated plasma glucose in which the threshold for diabetes has
not yet been reached and can predispose to the development of type 2 diabetes and …

[HTML][HTML] Diabetes, infection risk and COVID-19

S Erener - Molecular metabolism, 2020 - Elsevier
Background Individuals with diabetes are at a greater risk of hospitalization and mortality
resulting from viral, bacterial, and fungal infections. The coronavirus disease-2019 (COVID …

[PDF][PDF] Metabolic syndrome and COVID 19: endocrine-immune-vascular interactions shapes clinical course

R Bansal, S Gubbi, R Muniyappa - Endocrinology, 2020 - academic.oup.com
The ongoing coronavirus disease 2019 (COVID-19) pandemic is caused by the novel
coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Individuals …

Increased risk of COVID-19 in patients with diabetes mellitus—Current challenges in pathophysiology, treatment and prevention

T Gęca, K Wojtowicz, P Guzik, T Gora - International journal of …, 2022 - mdpi.com
Coronavirus disease—COVID-19 (coronavirus disease 2019) has become the cause of the
global pandemic in the last three years. Its etiological factor is SARS-CoV-2 (Severe Acute …

Effects of hyperglycemia and diabetes mellitus on coagulation and hemostasis

X Li, NC Weber, DM Cohn, MW Hollmann… - Journal of clinical …, 2021 - mdpi.com
In patients with diabetes, metabolic disorders disturb the physiological balance of
coagulation and fibrinolysis, leading to a prothrombotic state characterized by platelet …

Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy

W Sumaya, L Wallentin, SK James… - European heart …, 2018 - academic.oup.com
Aims To determine whether fibrin clot properties are associated with clinical outcomes
following acute coronary syndrome (ACS). Methods and results Plasma samples were …

Coagulatory defects in type-1 and type-2 diabetes

AIS Sobczak, AJ Stewart - International journal of molecular sciences, 2019 - mdpi.com
Diabetes (both type-1 and type-2) affects millions of individuals worldwide. A major cause of
death for individuals with diabetes is cardiovascular diseases, in part since both types of …

Effects of post-translational modifications of fibrinogen on clot formation, clot structure, and fibrinolysis: a systematic review

JJ de Vries, CJM Snoek, DC Rijken… - … , and vascular biology, 2020 - Am Heart Assoc
Objective: Post-translational modifications of fibrinogen influence the occurrence and
progression of thrombotic diseases. In this systematic review, we assessed the current …